Outsourcing

Articles

FDA approved hydroxychloroquine sulfate for emergency use as a treatment for some hospitalized patients with COVID-19. 

AMRI Announces Increased Production of Hydroxychloroquine Sulfate for COVID-19 Treatment

Wavelength Pharmaceuticals expanded production of APIs for certain pharmaceutical products needed to manage respiratory critical care patients in the COVID-19 pandemic.

Wavelength Pharmaceuticals Expands Supplies of Drug Ingredients for Managing COVID-19 and Adds API CDMO Services

Cambrex reports that the acquisition by the investment group will facilitate ongoing growth.

Cambrex Sale to Premira Funds Affiliate Closes

Lina Cogan is senior director of global sourcing and procurement for LGM Pharma.

Hamilton J. Lenox is senior vice-president, business development for LGM Pharma.

Selwyn Lustman is senior vice-president global sourcing and procurement for LGM Pharma.

Sourcing hard-to-find ingredients and establishing a reliable supply chain can stretch the resources of a small- to mid-size pharma company. 

Planning a Successful API Procurement Strategy

Jonathan Loughrey is head of screening, Cambrex Edinburgh.

An understanding-during early development-of the solid form landscape of an API can enhance product quality and manufacturing processes.

Uncovering Hidden Risks in Solid-State API Properties

The latest research from GlobalData has revealed that more than two-thirds (69%) of CMOs high-containment facilities are based in the top five European Union countries and Switzerland.

Majority of High-Containment CMO Facilities Located in 5EU and Switzerland, Notes GlobalData

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

The evolution of CDMOs has led to increased investment in new technologies, capabilities, and expertise.


The CDMO Evolution

To help customers succeed, CDMOs have moved away from the ‘fee-for-service’ model to offer flexible, full-service partnerships.

Partnering Up for Success

Complex and potent molecules demand greater technical and regulatory expertise to ensure safe handling.


In Safe Hands

Rita Peters is the former editorial director of 

Pharmaceutical Technology, Pharmaceutical Technology Europe

Pharmaceutical Technology spoke with Anil Kane, executive director, global science and technology, pharmaceutical development services, at Thermo Fisher Scientific about the industry’s need for more capacity in the manufacture of highly potent APIs.

Contract Manufacturing, Drug Substance, API